FDA staff voices concern about lorcaserin's safety and efficacy

09/14/2010 | Google

FDA reviewers said Arena Pharmaceutical's weight-loss drug lorcaserin meets the agency's efficacy standards "by a slim margin" and voiced concern about adverse effects. An advisory panel is scheduled Thursday to review the treatment.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA